glp 1 menopause symptoms GLP-1 Agonists in Perimenopause: Unique Risks and Potential Opportunities Semaglutide and Menopause: Does It

Generally, yes

The mechanism is still unknown

GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging

The US Food and Drug Administration (FDA) does not otherwise recommend routine thyroid monitoring [60]

Cygnus Technology) to PowerLab (AD Instruments)

Rotating your injection sites between the abdomen, thighs, and upper arms can also prevent lipodystrophy, a condition where fatty tissue builds up and forms hard lumps that may interfere with how your medication is absorbed